Zimmer Biomet Reports Q3 2026 Revenue of $2.06B, EPS of $1

Revenue rose 3.1% year over year to $2.06B. Net income attributable to the company fell 17% to $191.6M, and diluted EPS declined to $1 from $1.16; the prior-year quarter included favorable contingent-consideration adjustments that did not recur.